Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: PALMIRA Trial ...
MRD status before allo-HSCT is a strong prognostic factor for OS, DFS, and CIR in AML and MDS patients. MRD-negative patients showed significantly better OS and DFS compared to MRD-positive patients, ...
Micro-Raman spectroscopy, integrated with statistical analysis, discriminates CLL prognostic groups, revealing biochemical heterogeneity beyond conventional molecular markers. The method identifies ...
Impact of declining renal function on bladder cancer (BC) mortality in the U.S. (1999-2023): A regression analysis using the CDC WONDER database. This is an ASCO Meeting Abstract from the 2025 ASCO ...
New data on nasal mucosal melanoma reveal prognostic differences and a key biomarker in the ICI era. Learn more about the ...
Objectives To investigate patients’ sports activities prior to and after arthroscopic rotator cuff repair (ARCR) and to better understand the relationship between patient, injury and sport-specific ...
A new study in The American Journal of Pathology suggests that perilipin 2 could serve as a prognostic factor and points to new potential lipid-based targets for treating lung adenocarcinoma. This ...
Please provide your email address to receive an email when new articles are posted on . A prediction model for early-stage classic Hodgkin lymphoma identified four factors associated with PFS outcomes ...
Background: To augment the availability of medical care for a population that is older and more ethnically diverse, the number of US medical schools is increasing and existing medical schools are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results